Sabiedrība ar ierobežotu atbildību "Abbott Laboratories Baltics"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 226 770 € (76% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2009–2025
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||||||
| Total current assets | 448 323 | 518 070 | 894 178 | 1 079 978 | 1 663 600 | 2 519 382 | 2 301 884 | 2 867 109 | 337 598 | 395 991 | 459 990 | 591 374 | 235 499 | 339 451 | 394 495 | 585 091 | 379 399 |
| Total non-current assets | 226 887 | 193 356 | 153 658 | 106 668 | 81 870 | 96 446 | 513 661 | 4582 | 2264 | 1430 | 674 | 4188 | 2975 | 1925 | 2956 | 3725 | 6723 |
| Total assets | 675 210 | 711 426 | 1 047 836 | 1 186 646 | 1 745 470 | 2 615 828 | 2 815 545 | 2 871 691 | 339 862 | 397 421 | 460 664 | 595 562 | 238 474 | 341 376 | 397 451 | 588 816 | 386 122 |
| Balance sheet — liabilities and equity | |||||||||||||||||
| Current liabilities | 198 417 | 133 542 | 326 560 | 313 092 | 248 999 | 338 602 | 70 670 | 74 251 | 102 145 | 115 103 | 112 950 | 163 115 | 135 521 | 146 590 | 160 651 | 290 903 | 309 503 |
| Non-current liabilities | 5666 | 5666 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 204 083 | 139 208 | 326 560 | 313 092 | 248 999 | 338 602 | 70 670 | 74 251 | 102 145 | 115 103 | 112 950 | 163 115 | 135 521 | 146 590 | 160 651 | 290 903 | 309 503 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 113 299 | 101 091 | 141 009 | 152 278 | 622 917 | 147 940 | 467 650 | 60 458 | 40 276 | 44 601 | 65 396 | 84 733 | 31 810 | 91 833 | 42 014 | 61 113 | 5476 |
| Total equity | 471 127 | 572 218 | 721 276 | 873 554 | 1 496 471 | 2 277 226 | 2 744 875 | 2 797 440 | 237 717 | 282 318 | 347 714 | 432 447 | 102 953 | 194 786 | 236 800 | 297 913 | 76 619 |
| Income statement | |||||||||||||||||
| Sales revenue | 1 491 166 | 1 303 874 | 2 299 452 | 2 334 665 | 2 215 866 | 2 402 322 | 584 590 | 604 564 | 579 125 | 638 379 | 758 227 | 899 130 | 886 252 | 1 023 475 | 1 208 496 | 1 285 268 | 1 395 520 |
| Operating profit | 131 331 | 123 384 | 208 420 | 212 242 | 715 628 | 183 984 | 554 437 | 69 960 | 52 645 | 46 693 | 66 004 | 85 565 | 80 824 | 93 043 | 47 000 | 63 703 | 66 453 |
| Profit before income tax | 131 331 | 122 963 | 205 742 | 191 312 | 708 425 | 183 293 | 551 282 | 69 796 | 52 935 | 46 457 | 65 933 | 85 160 | 80 824 | 92 714 | 45 418 | 64 900 | 64 616 |
| Profit for the reporting year | 113 299 | 101 091 | 141 009 | 152 278 | 622 917 | 147 940 | 467 650 | 60 458 | 40 276 | 44 601 | 65 396 | 84 733 | 31 810 | 91 833 | 42 014 | 61 113 | 5476 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||||||
| Employees | 23 | 20 | 30 | 31 | 29 | 26 | 3 | 4 | 4 | 6 | 8 | 10 | 9 | 9 | 9 | 9 | 9 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7893 | 2 599 999 | 0 | 0 | 0 | 361 304 | 0 | 0 | 0 | 226 770 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: Sabiedrība ar ierobežotu atbildību "Abbott Laboratories Baltics"
Overview
Sabiedrība ar ierobežotu atbildību "Abbott Laboratories Baltics" (reg. no. 50003693601) is a limited liability company. The company was registered in 2004 and has been in the register for 22 years. Registered address: Mārupes nov., Mārupe, Malduguņu iela 4.
Financial results
Revenue in 2025 was 1 395 520 €, up 8,6% on the previous year (1 285 268 €). Net profit for 2025 was 5476 € (0,4% of revenue). The company was profitable in all 17 published years. In 2025 the company had 9 employees. Revenue per employee was 155 058 €. At the end of 2025, total assets were 386 122 € and equity 76 619 € (19,8% of assets).
Management and owners
The board has 3 members. The sole owner of the company is Abbott Investments Luxembourg S.a r.l..
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.